Suchergebnisse - "Huang, Shou-Jie"

PubPharm (43)

1

Immunogenicity and safety of an ORF7-deficient skin-attenuated and neuro-attenuated live vaccine for varicella : a randomised, double-blind, controlled, phase 2a trial

enthalten in: The Lancet. Infectious diseases | 2024

von Pan, H. | Qiu, L. | Liang, Q. | +24

2

Profile of clinical characteristics and serologic markers of sporadic hepatitis E in a community cohort study

enthalten in: Emerging microbes & infections | 2023

von Tang, Z. | Wen, G. | Ying, D. | +12

3

Head-to-head immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18-26 years in China : a randomised blinded clinical trial

enthalten in: The Lancet. Infectious diseases | 2023

von Zhu, F. | Zhong, G. | Huang, W. | +21

CommentIn: Lancet Infect Dis. 2023 Nov;23(11):1215-1216. - PMID 37475117

4

Immunogenicity and safety of an Escherichia coli-produced human papillomavirus (types 6/11/16/18/31/33/45/52/58) L1 virus-like-particle vaccine : a phase 2 double-blind, randomized, controlled trial

enthalten in: Science bulletin | 2023

von Hu, Y. | Bi, Z. | Zheng, Y. | +24

5

Safety and immunogenicity of a skin- and neuro-attenuated live vaccine for varicella : a randomized, double-blind, controlled, dose-escalation and age de-escalation phase 1 clinical trial

enthalten in: The Lancet regional health. Western Pacific | 2023

von Mo, Z. | Huang, S. | Qiu, L. | +21

6

Safety and immunogenicity of an Escherichia coli-produced 9-valent human papillomavirus L1 virus-like particle vaccine (types 6/11/16/18/31/33/45/52/58) in healthy adults : an open-label, dose-escalation phase 1 clinical trial

enthalten in: The Lancet regional health. Western Pacific | 2023

von Chu, K. | Bi, Z. | Huang, W. | +20

7

Prognosis of hepatitis E infection in patients with chronic liver disease : A meta-analysis

enthalten in: Journal of viral hepatitis | 2023

von Qiu, L. | Huang, Y. | Quan, J. | +10

8

Prognosis of hepatitis E infection in patients with chronic liver disease : A meta‐analysis

enthalten in: Journal of Viral Hepatitis | 2023

von Qiu, L. | Huang, Y. | Quan, J. | +10

9

Efficacy, safety, and immunogenicity of an Escherichia coli-produced Human Papillomavirus (16 and 18) L1 virus-like-particle vaccine : end-of-study analysis of a phase 3, double-blind, randomised, controlled trial

enthalten in: The Lancet. Infectious diseases | 2022

von Zhao, F. | Wu, T. | Hu, Y. | +36

10

Safety and immunogenicity of an Escherichia coli-produced bivalent human papillomavirus type 6/11 vaccine : A dose-escalation, randomized, double-blind, placebo-controlled phase 1 trial

enthalten in: Human vaccines & immunotherapeutics | 2022

von Mo, Z. | Bi, Z. | Sheng, W. | +17

1
2
3
4
5
Nächster »
[5]